questionsmedicales.fr
Composés polycycliques
Composés macrocycliques
Lactames macrocycliques
Lactames macrocycliques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections bactériennes
Cultures bactériennes
Antibiotiques
Tests de sensibilité
Efficacité
Cultures positives
Imagerie médicale
Infections profondes
Symptômes
5
Symptômes
Infections bactériennes
Effets secondaires
Eruptions cutanées
Réaction allergique
Démangeaisons
Prévention
5
Prophylaxie
Infections post-chirurgicales
Vaccinations
Infections bactériennes
Résistance aux antibiotiques
Prescriptions médicales
Traitements
5
Administration
Voie intraveineuse
Mécanisme d'action
Paroi cellulaire
Durée du traitement
Infections
Effets secondaires
Ajustement du traitement
Complications
5
Complications
Réactions allergiques
Surinfection
Évaluation médicale
Troubles rénaux
Surveillance
Réaction sévère
Urgence médicale
Interactions médicamenteuses
Médecin
Facteurs de risque
5
Facteurs de risque
Immunodépression
Antécédents médicaux
Allergies
Personnes âgées
Système immunitaire
Voyages
Agents pathogènes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lactames macrocycliques : Questions médicales les plus fréquentes",
"headline": "Lactames macrocycliques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lactames macrocycliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-19",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lactames macrocycliques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés macrocycliques",
"url": "https://questionsmedicales.fr/mesh/D047028",
"about": {
"@type": "MedicalCondition",
"name": "Composés macrocycliques",
"code": {
"@type": "MedicalCode",
"code": "D047028",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maitansine",
"alternateName": "Maytansine",
"url": "https://questionsmedicales.fr/mesh/D008453",
"about": {
"@type": "MedicalCondition",
"name": "Maitansine",
"code": {
"@type": "MedicalCode",
"code": "D008453",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Rifamycine",
"alternateName": "Rifamycins",
"url": "https://questionsmedicales.fr/mesh/D012294",
"about": {
"@type": "MedicalCondition",
"name": "Rifamycine",
"code": {
"@type": "MedicalCode",
"code": "D012294",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Rifabutine",
"alternateName": "Rifabutin",
"url": "https://questionsmedicales.fr/mesh/D017828",
"about": {
"@type": "MedicalCondition",
"name": "Rifabutine",
"code": {
"@type": "MedicalCode",
"code": "D017828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.650"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Streptovarycine",
"alternateName": "Streptovaricin",
"url": "https://questionsmedicales.fr/mesh/D013310",
"about": {
"@type": "MedicalCondition",
"name": "Streptovarycine",
"code": {
"@type": "MedicalCode",
"code": "D013310",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.650.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Streptovarycine",
"alternateName": "Streptovaricin",
"url": "https://questionsmedicales.fr/mesh/D013310",
"about": {
"@type": "MedicalCondition",
"name": "Streptovarycine",
"code": {
"@type": "MedicalCode",
"code": "D013310",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.650.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Rifampicine",
"alternateName": "Rifampin",
"url": "https://questionsmedicales.fr/mesh/D012293",
"about": {
"@type": "MedicalCondition",
"name": "Rifampicine",
"code": {
"@type": "MedicalCode",
"code": "D012293",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Rifaximine",
"alternateName": "Rifaximin",
"url": "https://questionsmedicales.fr/mesh/D000078262",
"about": {
"@type": "MedicalCondition",
"name": "Rifaximine",
"code": {
"@type": "MedicalCode",
"code": "D000078262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.345.295.750.850"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lactames macrocycliques",
"alternateName": "Lactams, Macrocyclic",
"code": {
"@type": "MedicalCode",
"code": "D047029",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jonathan L Sessler",
"url": "https://questionsmedicales.fr/author/Jonathan%20L%20Sessler",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712-1224, United States."
}
},
{
"@type": "Person",
"name": "Chunju Li",
"url": "https://questionsmedicales.fr/author/Chunju%20Li",
"affiliation": {
"@type": "Organization",
"name": "College of Sciences, Center for Supramolecular Chemistry and Catalysis, Shanghai University, Shanghai, 200444, People's Republic of China. cjli@shu.edu.cn."
}
},
{
"@type": "Person",
"name": "Zhongzhen Yang",
"url": "https://questionsmedicales.fr/author/Zhongzhen%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk."
}
},
{
"@type": "Person",
"name": "Adrian C Whitwood",
"url": "https://questionsmedicales.fr/author/Adrian%20C%20Whitwood",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk."
}
},
{
"@type": "Person",
"name": "William P Unsworth",
"url": "https://questionsmedicales.fr/author/William%20P%20Unsworth",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Contact Tracing: Barriers and Facilitators.",
"datePublished": "2022-06-02",
"url": "https://questionsmedicales.fr/article/35653650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2105/AJPH.2022.306842"
}
},
{
"@type": "ScholarlyArticle",
"name": "Privacy and contact tracing efficacy.",
"datePublished": "2022-09-21",
"url": "https://questionsmedicales.fr/article/36128709",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsif.2022.0369"
}
},
{
"@type": "ScholarlyArticle",
"name": "Contact tracing: Characteristics of COVID-19 cases that provided contacts.",
"datePublished": "2023-11-02",
"url": "https://questionsmedicales.fr/article/37917769",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0293208"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Recommendations for contact tracing for tuberculosis - update 2023].",
"datePublished": "2023-08-03",
"url": "https://questionsmedicales.fr/article/37536363",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2107-2147"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Recommendations for Contact Tracing for Tuberculosis - Update 2023].",
"datePublished": "2023-11-16",
"url": "https://questionsmedicales.fr/article/37972583",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2148-7769"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés polycycliques",
"item": "https://questionsmedicales.fr/mesh/D011083"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés macrocycliques",
"item": "https://questionsmedicales.fr/mesh/D047028"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lactames macrocycliques",
"item": "https://questionsmedicales.fr/mesh/D047029"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lactames macrocycliques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lactames macrocycliques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lactames macrocycliques",
"description": "Comment diagnostiquer une infection bactérienne ?\nQuels tests sont utilisés pour les lactames macrocycliques ?\nQuels symptômes indiquent une infection nécessitant des lactames ?\nComment évaluer l'efficacité des lactames macrocycliques ?\nQuels examens d'imagerie sont utiles ?",
"url": "https://questionsmedicales.fr/mesh/D047029?mesh_terms=Contact+Tracing#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lactames macrocycliques",
"description": "Quels sont les symptômes d'une infection bactérienne ?\nLes lactames provoquent-ils des effets secondaires ?\nComment reconnaître une réaction allergique ?\nQuels signes d'infection nécessitent une attention médicale ?\nLes lactames macrocycliques affectent-ils le système digestif ?",
"url": "https://questionsmedicales.fr/mesh/D047029?mesh_terms=Contact+Tracing#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lactames macrocycliques",
"description": "Comment prévenir les infections bactériennes ?\nLes lactames macrocycliques sont-ils utilisés en prophylaxie ?\nQuelles mesures d'hygiène sont recommandées ?\nLes vaccinations aident-elles contre les infections ?\nComment éviter la résistance aux antibiotiques ?",
"url": "https://questionsmedicales.fr/mesh/D047029?mesh_terms=Contact+Tracing#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lactames macrocycliques",
"description": "Comment les lactames macrocycliques sont-ils administrés ?\nQuel est le mécanisme d'action des lactames ?\nCombien de temps dure un traitement typique ?\nQuels antibiotiques sont des lactames macrocycliques ?\nComment gérer les effets secondaires des lactames ?",
"url": "https://questionsmedicales.fr/mesh/D047029?mesh_terms=Contact+Tracing#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lactames macrocycliques",
"description": "Quelles complications peuvent survenir avec les lactames ?\nComment gérer une surinfection ?\nLes lactames peuvent-ils causer des troubles rénaux ?\nQuels sont les signes d'une réaction sévère ?\nLes lactames macrocycliques peuvent-ils interagir avec d'autres médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D047029?mesh_terms=Contact+Tracing#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lactames macrocycliques",
"description": "Quels facteurs augmentent le risque d'infection ?\nLes antécédents d'allergies influencent-ils le traitement ?\nLe mode de vie affecte-t-il le risque d'infection ?\nLes personnes âgées sont-elles plus à risque ?\nLes voyages augmentent-ils le risque d'infections ?",
"url": "https://questionsmedicales.fr/mesh/D047029?mesh_terms=Contact+Tracing#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection bactérienne ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les lactames macrocycliques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de sensibilité aux antibiotiques sont effectués pour évaluer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection nécessitant des lactames ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, inflammation et signes d'infection localisée peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des lactames macrocycliques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'amélioration clinique et la réduction des cultures positives."
}
},
{
"@type": "Question",
"name": "Quels examens d'imagerie sont utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des radiographies ou IRM peuvent être utilisées pour évaluer des infections profondes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection bactérienne ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, douleur, rougeur et gonflement au site d'infection sont fréquents."
}
},
{
"@type": "Question",
"name": "Les lactames provoquent-ils des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des éruptions cutanées ou des troubles gastro-intestinaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, un gonflement ou des difficultés respiratoires peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection nécessitent une attention médicale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une fièvre élevée persistante ou des douleurs intenses doivent être évaluées par un médecin."
}
},
{
"@type": "Question",
"name": "Les lactames macrocycliques affectent-ils le système digestif ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer des nausées, vomissements ou diarrhées chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections bactériennes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène, des vaccinations et un usage prudent des antibiotiques aident à prévenir."
}
},
{
"@type": "Question",
"name": "Les lactames macrocycliques sont-ils utilisés en prophylaxie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés en prophylaxie pour prévenir des infections post-chirurgicales."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le contact avec des personnes malades sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles contre les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infections bactériennes spécifiques."
}
},
{
"@type": "Question",
"name": "Comment éviter la résistance aux antibiotiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser les antibiotiques uniquement lorsque nécessaire et suivre les prescriptions médicales."
}
},
{
"@type": "Question",
"name": "Comment les lactames macrocycliques sont-ils administrés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par voie intraveineuse ou orale, selon l'infection."
}
},
{
"@type": "Question",
"name": "Quel est le mécanisme d'action des lactames ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la synthèse de la paroi cellulaire bactérienne, entraînant la mort des bactéries."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement typique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais elle est généralement de 7 à 14 jours selon l'infection."
}
},
{
"@type": "Question",
"name": "Quels antibiotiques sont des lactames macrocycliques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exemples incluent la méropénème et l'imipénème, utilisés pour des infections graves."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires des lactames ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est important de signaler tout effet indésirable au médecin pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les lactames ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques graves ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer une surinfection ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation médicale est nécessaire pour ajuster le traitement et cibler la nouvelle infection."
}
},
{
"@type": "Question",
"name": "Les lactames peuvent-ils causer des troubles rénaux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains lactames peuvent affecter la fonction rénale, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une réaction sévère ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des difficultés respiratoires ou un gonflement du visage nécessitent une urgence."
}
},
{
"@type": "Question",
"name": "Les lactames macrocycliques peuvent-ils interagir avec d'autres médicaments ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent interagir avec d'autres médicaments, il est donc important d'informer le médecin."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le diabète et les interventions chirurgicales augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies influencent-ils le traitement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies aux antibiotiques peuvent limiter les options de traitement."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un système immunitaire affaibli, les rendant plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infections ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à des agents pathogènes inconnus, augmentant le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 15/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Chemistry, The University of Texas at Austin, Austin, Texas 78712-1224, United States.
Publications dans "Lactames macrocycliques" :
3 publications dans cette catégorie
Affiliations :
College of Sciences, Center for Supramolecular Chemistry and Catalysis, Shanghai University, Shanghai, 200444, People's Republic of China. cjli@shu.edu.cn.
Tianjin Key Laboratory of Structure and Performance for Functional Molecules, College of Chemistry, Tianjin Normal University, Tianjin, 300387, People's Republic of China. cjli@shu.edu.cn.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Kuwait University, P.O. Box 5969, Safat 13060, Kuwait.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Kuwait University, P.O. Box 5969, Safat 13060, Kuwait.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, People's Republic of China.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, People's Republic of China.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
Tianjin Key Laboratory of Structure and Performance for Functional Molecules, College of Chemistry, Tianjin Normal University, Tianjin, 300387, People's Republic of China.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
Centro de Investigacións Cientı́ficas Avanzadas (CICA) and Departamento de Quı́mica, Universidade da Coruña, Campus da Zapateira-Rúa da Fraga 10, 15008 A Coruña, Spain.
Publications dans "Lactames macrocycliques" :
2 publications dans cette catégorie
Affiliations :
Centro de Investigacións Cientı́ficas Avanzadas (CICA) and Departamento de Quı́mica, Universidade da Coruña, Campus da Zapateira-Rúa da Fraga 10, 15008 A Coruña, Spain.
Publications dans "Lactames macrocycliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Green Prevention and Control of Tropical Plant Diseases and Pests, Ministry of Education, College of Plant Protection, Hainan University, Haikou 570228, China.
Publications dans "Lactames macrocycliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Green Prevention and Control of Tropical Plant Diseases and Pests, Ministry of Education, College of Plant Protection, Hainan University, Haikou 570228, China.
Publications dans "Lactames macrocycliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Green Prevention and Control of Tropical Plant Diseases and Pests, Ministry of Education, College of Plant Protection, Hainan University, Haikou 570228, China.
Publications dans "Lactames macrocycliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Green Prevention and Control of Tropical Plant Diseases and Pests, Ministry of Education, College of Plant Protection, Hainan University, Haikou 570228, China.
Publications dans "Lactames macrocycliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Green Prevention and Control of Tropical Plant Diseases and Pests, Ministry of Education, College of Plant Protection, Hainan University, Haikou 570228, China.
Publications dans "Lactames macrocycliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Green Prevention and Control of Tropical Plant Diseases and Pests, Ministry of Education, College of Plant Protection, Hainan University, Haikou 570228, China.
Publications dans "Lactames macrocycliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of York, Heslington York YO10 5DD UK William.unsworth@york.ac.uk.
Publications dans "Lactames macrocycliques" :
1 publication dans cette catégorie
Affiliations :
Natural Products Research Institute, College of Pharmacy , Seoul National University , Seoul 08826 , Republic of Korea.
Publications dans "Lactames macrocycliques" :
Contact tracing-the process of identifying, isolating, and managing infected persons and their contacts-is a recognized public health measure for controlling the transmission of infectious diseases. I...
As the COVID-19 pandemic emerged, public health authorities and software designers considered the possibility that smartphones could be used for contact tracing to control disease spread. Smartphone-b...
This cross-sectional study evaluated COVID-19 contact tracing efforts to identify variations in contact tracing outcomes in different population subgroups. Contact tracing was a critical tool to slow ...
The aim of contact tracing for tuberculosis is in addition to active case finding the detection of chains of infection and the prevention of the further spread of the disease. In this context, a caref...
The aim of contact tracing for tuberculosis is in addition to active case finding the detection of chains of infection and the prevention of the further spread of the disease. In this context, a caref...
In Ghana, contact tracing received heightened attention in the fight against the COVID-19 pandemic during its peak period. Despite the successes achieved, numerous challenges continue to limit the eff...
Using a focus group discussion (FGD) approach, an exploratory qualitative design was conducted in six selected districts of the Bono region of Ghana in this study. The purposeful sampling technique wa...
The discussants reported twelve (12) challenges that hindered effective contact tracing in the Bono region. These include inadequate personal protective equipment, harassment by contacts, politicisati...
There is a need for health authorities, particularly in the region, and the state as a whole to address contact tracing-related challenges while simultaneously harnessing the recommended opportunities...
Contact tracing is one of the most effective non-pharmaceutical interventions in the COVID-19 pandemic. This study uses a multi-agent model to investigate the impact of four types of contact tracing s...
In order to analyse individual contact tracing in a reasonably realistic setup, we construct an agent-based model of a small municipality with about 60.000 inhabitants (nodes) and about 2.8 million so...
There are four main findings in our paper. 1. In general, local closures are more effective than any type of tracing. 2. In an environment with strict contact restrictions there are only small differe...
In situations, where many other non-pharmaceutical interventions are in place, the specific extent of contact tracing may not have a large influence on their effectiveness. In a more relaxed setting w...
In Korea, contact tracing for coronavirus disease 2019 is conducted using information from credit card records, handwritten visitor logs, KI-Pass (QR code), and the Safe Call system after an interview...
An anonymous survey was conducted for 2 months (July to September 2021) among contact tracers throughout Korea. The questionnaire consisted of 4 parts: (1) demographic characteristics; (2) the usefuln...
In total, 190 individuals completed the survey. When asked to rate the usefulness of each tool for contact tracing on a Likert scale, most respondents (86.3%) provided positive responses for credit ca...
Over 80% of participants provided positive responses for credit card records, KI-Pass, and Safe Call data, while approximately 50% provided negative responses regarding the usefulness of handwritten v...
Initial COVID-19 surges in the United States created a need for technology to supplement human resources to increase efficiency and efficacy....
Resolve to Save Lives worked with jurisdictions to co-design four technology solutions-Epi Viaduct data pipeline, Epi Contacts contact elicitation webform, Epi Locator contact information search plugi...
Epi Viaduct accelerated the transfer of approximately 7,400,000 records from an electronic laboratory reporting system in a single jurisdiction to the respective CMS from more than 2.5 hours to less t...
Systems to mount large-scale population-based contact tracing programs were developed and implemented during the COVID-19 pandemic and can be adapted for CI/CT programs aiming to control the spread of...
We adopt a maximum-likelihood framework to estimate parameters of a stochastic susceptible-infected-recovered (SIR) model with contact tracing on a rooted random tree. Given the number of detectees pe...